Cargando…
Chemotherapy-Associated Thrombotic Microangiopathy
Thrombotic microangiopathy (TMA) is a syndrome of microangiopathic hemolytic anemia and thrombocytopenia with end-organ dysfunction. Although the advent of plasma exchange, immunosuppression, and complement inhibition has improved morbidity and mortality for primary TMAs, the management of secondary...
Autores principales: | Aklilu, Abinet M., Shirali, Anushree C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Nephrology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103319/ https://www.ncbi.nlm.nih.gov/pubmed/36706238 http://dx.doi.org/10.34067/KID.0000000000000061 |
Ejemplares similares
-
Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012) -
Influenza-associated thrombotic microangiopathies
por: Bitzan, Martin, et al.
Publicado: (2017) -
Cancer-associated thrombotic microangiopathy
por: Govind Babu, K, et al.
Publicado: (2016) -
Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020) -
Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)